Dantrolene inhibits nitric oxide synthase in rat alveolar macrophages treated with lipopolysaccharide and interferon-γ

Canadian Journal of Anaesthesia

Volumn 45, Issue 3, 1998, Pages 246-252

  Li, Chi Yuan ^a,c   Chou, Tz Chong ^a   Wu, Chin Chen ^a   Wong, Chih Shung ^a   Ho, Shung Tai ^a   Yen, Mao Hsiung ^a   Ding, Yu An ^b  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c Department of Anesthesiology ^*  (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DANTROLENE; GAMMA INTERFERON; LIPOPOLYSACCHARIDE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ARTICLE; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; LUNG ALVEOLUS MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SARCOPLASMIC RETICULUM;

EID: 0031747440     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03012910     Document Type: Article

References (29)

1. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-42.
2. Förstermann U, Schmidt HHHW, Pollock JS, et al. Isoforms of nitric oxide synthase. Characterization and purification from different cell types. Biochem Pharmacol 1991; 42: 1849-57.
3. Xie Q-VV, Cho HJ, Calaycay J, et al. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992; 256: 225-8.
4. Ding AH, Nathan CF, Stuehr DJ. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 1988; 141: 2407-12.
5. Geller DA, Lowenstein CJ, Shapiro RA, et al. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci 1993; 90: 3491-5.
6. Nathan CF, Hibbs JB Jr. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 1991; 3: 65-70.
7. Szabó C, Mitchell JA, Thiemermann C, Vane JR. Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br J Pharmacol 1993; 108: 786-92.
8. 2+ pool depletion is linked to the induction of nitric oxide synthesis in murine peritoneal macrophages. Biochem Mol Biol Int 1995; 36: 949-55.
9. Bosson S, Kuenzig M, Schwartz SI. Verapamil improves cardiac function and increases survival in canine E. cold endotoxin shock. Circ Shock 1985; 16: 307-16.
10. Lee HC, Lum BKB. Protective action of calcium entry blockers in endotoxin shock. Circ Shock 1986; 18: 193-203.
11. Szabó C, Mitchell JA, Gross SS, Thiemermann C, Vane JR. Nifedipine inhibits the induction of nitric oxide synthase by bacterial lipopolysaccharide. J Pharmacol Exp Ther 1993; 265: 674-80.
12. Ward A, Chaffman MO, Sorkin EM. Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity. Drugs 1986; 32: 130-68.
13. HainautK, Desmedt JE. Effect of dantrolene sodium on calcium movements in single muscle fibres. Nature 1974; 252: 728-9.
14. Van Winkle WB. Calcium release from skeletal muscle sarcoplasmic reticulum: site of action of dantrolene sodium? Science 1976; 193: 1130-1.
15. 2+: a critical link in the pathophysiology of sepsis? Proc Natl Acad Sci USA 1993; 90: 3933-7.
16. Hotchkiss RS, Karl IE. Dantrolene ameliorates the metabolic hallmarks of sepsis in rats and improves survival in a mouse model of endotoxemia. Proc Natl Acad Sci USA 1994; 91: 3039-43.
17. Wu C-C, Yen M-H. Beneficial effects of dantrolene on lipopolysaccharide-induced haemodynamic alternations in rats and mortality in mice. Eur J Pharmocol 1997; 327: 17-24.
18. Li C-Y, Chou T-C, Wong C-S, et al. Ketamine inhibits nitric oxide synthase in lipopolysaccharide-treated rat alveolar macrophages. Can J Anaesth 1997; 44: 989-95.
19. Gross SS, Levi R. Tetrabydrobiopterin synthesis. An absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle. J Biol Chem 1992; 267: 25722-9.
20. Waage A. Production and clearance of tumor necrosis factor in rats exposed to endotoxin and dexamethasone. Clin Immunol Immunopathol 1987; 45: 348-55.
21. Zuckerman SH, Stellhaas J, Butler LD. Differential regulation of lipopolysacharide-induced interleukin-1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis. Eur J Immunol 1989; 19: 301-5.
22. Hattori Y, Kasai K, So S, Hattori S, Banba N, Shimoda S-I. Effects of calcium channel antagonists on the induction of nitric oxide synthase in cultured cells by immunostimulants. Life Sci 1995; 57: 1833-40.
23. Lo C-J, Garcia I, Cryer G, Maier RV. Calcium and calmodulin regulate lipopolysaccharide-induced alveolar macrophage production of tumor necrosis factor and procoagulant activity. Arch surg 1996; 131: 44-50.
24. Denlinger LC, Fisette PL, Garis KA, et al. Regulation of inducible nitric oxide synthase expression by macrophage purinoreceptors and calcium. J Biol Chem 1996; 271: 337-42.
25. Malcolm DS, Zaloga GP, Holaday JW. Calcium administration increases the mortality of endotoxic shock in rats. Crit Care Med 1989; 17: 900-3.
26. Zaloga GP, Sager A, Black RW, Prielipp R. Low dose calcium administration increases mortality during septic peritonitis in rats. Circ Shock 1992; 37: 226-9.
27. Pinsky MR, Vincent J-L, Deviere J. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 1993; 103: 565-75.
28. Fisher CJ Jr, Opal SM, Dhainaut J-F, et al. Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine level in patients with sepsis. Crit Care Med 1993; 21: 318-27.
29. Hotchliss RS, Osborne DF, Lappas GD, Karl IE. Calcium antagonists decrease plasma and tissue concentrations of tumor necrosis factor-α, interleukin-1 ß, and interleukin-1 α in a mouse model of endotoxin. Shock 1995; 3: 337-42.